article thumbnail

What’s Next for the NIH When it Comes to Psychedelics?

Veriheal

Collins has said that the DEA recently “granted permission to expand the number of research marijuana providers” but that the best solution would still be to remove cannabis from its scheduling and to alter the scheduling of other psychedelics to make the much-needed researcher easier. .